NGNE
Neurogene Inc.
-0.93 (-2.68%)33.74USD47.6K成交股數675M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-12下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 5 · 340K · 1 |
| 其中 10b5-1 計畫賣出 | 5 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 787K |
| 近 180 天 淨額 | −787K |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-07 | 07-07 | Cvijic Christine Mikail | President and CFO | S 公開市場賣出(10b5-1) | 4.2K | 36.13 | 152K | 84.0K | SEC |
| 2026-07-06 | 07-07 | Cvijic Christine Mikail | President and CFO | S 公開市場賣出(10b5-1) | 600 | 36.02 | 22K | 88.2K | SEC |
| 2026-07-02 | 07-02 | Cvijic Christine Mikail | President and CFO | S 公開市場賣出(10b5-1) | 1.5K | 35.23 | 54K | 88.8K | SEC |
| 2026-07-02 | 07-02 | Cvijic Christine Mikail | President and CFO | S 公開市場賣出(10b5-1) | 2.5K | 34.58 | 88K | 90.4K | SEC |
| 2026-07-01 | 07-02 | Cvijic Christine Mikail | President and CFO | S 公開市場賣出(10b5-1) | 739 | 34.06 | 25K | 92.9K | SEC |
| 2026-05-06 | 05-08 | Cvijic Christine Mikail | President and CFO | S 公開市場賣出(10b5-1) | 4.8K | 32.44 | 156K | 93.6K | SEC |
| 2026-05-06 | 05-08 | Cvijic Christine Mikail | President and CFO | S 公開市場賣出(10b5-1) | 4.8K | 30.07 | 144K | 98.4K | SEC |
| 2026-03-26 | 03-30 | Cvijic Christine Mikail | President and CFO | S 公開市場賣出(10b5-1) | 2.6K | 21.62 | 55K | 103K | SEC |
| 2026-03-26 | 03-30 | McMinn Rachel | Chief Executive Officer | S 公開市場賣出(10b5-1) | 3.4K | 22.07 | 74K | 1.3M | SEC |
| 2026-03-26 | 03-30 | Jordan Julie | Chief Medical Officer | S 公開市場賣出(10b5-1) | 828 | 21.89 | 18K | 12.5K | SEC |
| 2026-03-13 | 03-17 | Cobb Stuart | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 4.0K | 20.41 | 81K | 33.3K | SEC |
| 2026-03-13 | 03-17 | Cvijic Christine Mikail | President and CFO | S 公開市場賣出(10b5-1) | 1.4K | 21.25 | 30K | 106K | SEC |
| 2026-03-13 | 03-17 | Cvijic Christine Mikail | President and CFO | S 公開市場賣出(10b5-1) | 263 | 22.02 | 6K | 106K | SEC |
| 2026-03-13 | 03-17 | Cobb Stuart | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 2.7K | 21.34 | 57K | 30.6K | SEC |
| 2026-03-13 | 03-17 | Cobb Stuart | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 148 | 22.08 | 3K | 30.5K | SEC |
| 2026-03-13 | 03-17 | Cvijic Christine Mikail | President and CFO | S 公開市場賣出(10b5-1) | 2.4K | 20.42 | 49K | 107K | SEC |
| 2026-02-27 | 03-03 | Cvijic Christine Mikail | President and CFO | S 公開市場賣出(10b5-1) | 4.8K | 25.11 | 121K | 110K | SEC |
| 2026-02-20 | 02-24 | Jordan Julie | Chief Medical Officer | A 獲配股票 | 4.9K | – | – | 13.3K | SEC |
| 2026-02-20 | 02-24 | McMinn Rachel | Chief Executive Officer | A 獲配股票 | 25.9K | – | – | 1.3M | SEC |
| 2026-02-20 | 02-24 | Cvijic Christine Mikail | President and CFO | A 獲配股票 | 22.0K | – | – | 115K | SEC |
| 2026-02-20 | 02-24 | Cobb Stuart | Chief Scientific Officer | A 獲配股票 | 16.5K | – | – | 37.3K | SEC |
| 2025-05-14 | 05-15 | Cobb Stuart | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 6.8K | 15.15 | 103K | 20.8K | SEC |
| 2025-03-26 | 03-28 | McMinn Rachel | Chief Executive Officer | A 獲配股票 | 23.9K | – | – | 1.3M | SEC |
| 2025-03-26 | 03-28 | Jordan Julie | Chief Medical Officer | A 獲配股票 | 8.4K | – | – | 8.4K | SEC |
| 2025-03-26 | 03-28 | Cobb Stuart | Chief Scientific Officer | A 獲配股票 | 7.2K | – | – | 27.6K | SEC |
| 2025-03-26 | 03-28 | Cvijic Christine Mikail | President and CFO | A 獲配股票 | 20.3K | – | – | 92.6K | SEC |
| 2025-03-13 | 03-17 | Cvijic Christine Mikail | President and CFO | S 公開市場賣出(10b5-1) | 4.5K | 16.94 | 76K | 72.3K | SEC |
| 2024-11-26 | 11-27 | AKKARAJU SRINIVAS | TenPercentOwner | P 公開市場買進 | 2.0K | 27.50 | 55K | 1.7M | SEC |
| 2024-11-26 | 11-27 | AKKARAJU SRINIVAS | TenPercentOwner | P 公開市場買進 | 15.2K | 26.73 | 407K | 1.7M | SEC |
| 2024-11-26 | 11-27 | AKKARAJU SRINIVAS | TenPercentOwner | P 公開市場買進 | 10.8K | 26.01 | 281K | 1.7M | SEC |
| 2024-11-26 | 11-27 | Samsara BioCapital, L.P. | TenPercentOwner | P 公開市場買進 | 20.7K | 24.91 | 517K | 1.7M | SEC |
| 2024-11-26 | 11-27 | AKKARAJU SRINIVAS | TenPercentOwner | P 公開市場買進 | 20.7K | 24.91 | 517K | 1.7M | SEC |
| 2024-11-26 | 11-27 | Samsara BioCapital GP, LLC | TenPercentOwner | P 公開市場買進 | 20.7K | 24.91 | 517K | 1.7M | SEC |
| 2024-11-26 | 11-27 | Samsara BioCapital GP, LLC | TenPercentOwner | P 公開市場買進 | 15.2K | 26.73 | 407K | 1.7M | SEC |
| 2024-11-26 | 11-27 | Samsara BioCapital, L.P. | TenPercentOwner | P 公開市場買進 | 2.0K | 27.50 | 55K | 1.7M | SEC |
| 2024-11-26 | 11-27 | Samsara BioCapital GP, LLC | TenPercentOwner | P 公開市場買進 | 2.0K | 27.50 | 55K | 1.7M | SEC |
| 2024-11-26 | 11-27 | Samsara BioCapital, L.P. | TenPercentOwner | P 公開市場買進 | 10.8K | 26.01 | 281K | 1.7M | SEC |
| 2024-11-26 | 11-27 | Samsara BioCapital, L.P. | TenPercentOwner | P 公開市場買進 | 15.2K | 26.73 | 407K | 1.7M | SEC |
| 2024-11-26 | 11-27 | Samsara BioCapital GP, LLC | TenPercentOwner | P 公開市場買進 | 10.8K | 26.01 | 281K | 1.7M | SEC |
| 2024-11-22 | 11-25 | McMinn Rachel | Chief Executive Officer | P 公開市場買進 | 47.5K | 20.40 | 969K | 1.3M | SEC |
| 2024-11-22 | 11-25 | Cvijic Christine Mikail | President and CFO | P 公開市場買進 | 24.0K | 20.48 | 492K | 76.8K | SEC |
| 2024-03-13 | 03-14 | Cvijic Christine Mikail | President and CFO | A 獲配股票 | 31.9K | – | – | 52.8K | SEC |
| 2024-03-13 | 03-14 | Cobb Stuart | Chief Scientific Officer | A 獲配股票 | 20.4K | – | – | 20.4K | SEC |
| 2023-10-05 | 10-10 | BAKER BROS. ADVISORS LP | Director,TenPercentOwner | X 選擇權履約 | 57.0K | – | – | 156K | SEC |
| 2023-10-05 | 10-10 | BAKER JULIAN | Director,TenPercentOwner | X 選擇權履約 | 57.0K | – | – | 156K | SEC |
| 2023-10-05 | 10-10 | Baker Bros. Advisors (GP) LLC | Director,TenPercentOwner | X 選擇權履約 | 57.0K | – | – | 156K | SEC |
| 2023-10-05 | 10-10 | 667, L.P. | Director,TenPercentOwner | X 選擇權履約 | 536K | – | – | 1.7M | SEC |
| 2023-10-05 | 10-10 | 667, L.P. | Director,TenPercentOwner | X 選擇權履約 | 57.0K | – | – | 156K | SEC |
| 2023-10-05 | 10-10 | Baker Brothers Life Sciences LP | Director,TenPercentOwner | X 選擇權履約 | 536K | – | – | 1.7M | SEC |
| 2023-10-05 | 10-10 | Baker Brothers Life Sciences LP | Director,TenPercentOwner | X 選擇權履約 | 57.0K | – | – | 156K | SEC |
| 2023-10-05 | 10-10 | BAKER BROS. ADVISORS LP | Director,TenPercentOwner | X 選擇權履約 | 536K | – | – | 1.7M | SEC |
| 2023-10-05 | 10-10 | BAKER FELIX | Director,TenPercentOwner | X 選擇權履約 | 536K | – | – | 1.7M | SEC |
| 2023-10-05 | 10-10 | BAKER FELIX | Director,TenPercentOwner | X 選擇權履約 | 57.0K | – | – | 156K | SEC |
| 2023-10-05 | 10-10 | Baker Bros. Advisors (GP) LLC | Director,TenPercentOwner | X 選擇權履約 | 536K | – | – | 1.7M | SEC |
| 2023-10-05 | 10-10 | BAKER JULIAN | Director,TenPercentOwner | X 選擇權履約 | 536K | – | – | 1.7M | SEC |
| 2023-08-17 | 08-17 | Baker Bros. Advisors (GP) LLC | Director,TenPercentOwner | P 公開市場買進 | 7.7K | 0.69 | 5K | 489K | SEC |
| 2023-08-17 | 08-17 | BAKER BROS. ADVISORS LP | Director,TenPercentOwner | P 公開市場買進 | 5.0K | 0.69 | 3K | 494K | SEC |
| 2023-08-17 | 08-17 | Baker Bros. Advisors (GP) LLC | Director,TenPercentOwner | P 公開市場買進 | 93.1K | 0.69 | 64K | 5.6M | SEC |
| 2023-08-17 | 08-17 | BAKER BROS. ADVISORS LP | Director,TenPercentOwner | P 公開市場買進 | 93.1K | 0.69 | 64K | 5.6M | SEC |
| 2023-08-17 | 08-17 | Baker Bros. Advisors (GP) LLC | Director,TenPercentOwner | P 公開市場買進 | 5.0K | 0.69 | 3K | 494K | SEC |
| 2023-08-17 | 08-17 | Baker Bros. Advisors (GP) LLC | Director,TenPercentOwner | P 公開市場買進 | 61.1K | 0.69 | 42K | 5.6M | SEC |
| 2023-08-17 | 08-17 | BAKER BROS. ADVISORS LP | Director,TenPercentOwner | P 公開市場買進 | 61.1K | 0.69 | 42K | 5.6M | SEC |
| 2023-08-17 | 08-17 | 667, L.P. | Director,TenPercentOwner | P 公開市場買進 | 5.0K | 0.69 | 3K | 494K | SEC |
| 2023-08-17 | 08-17 | BAKER FELIX | Director,TenPercentOwner | P 公開市場買進 | 5.0K | 0.69 | 3K | 494K | SEC |
| 2023-08-17 | 08-17 | BAKER FELIX | Director,TenPercentOwner | P 公開市場買進 | 93.1K | 0.69 | 64K | 5.6M | SEC |
| 2023-08-17 | 08-17 | BAKER FELIX | Director,TenPercentOwner | P 公開市場買進 | 7.7K | 0.69 | 5K | 489K | SEC |
| 2023-08-17 | 08-17 | Baker Brothers Life Sciences LP | Director,TenPercentOwner | P 公開市場買進 | 5.0K | 0.69 | 3K | 494K | SEC |
| 2023-08-17 | 08-17 | Baker Brothers Life Sciences LP | Director,TenPercentOwner | P 公開市場買進 | 61.1K | 0.69 | 42K | 5.6M | SEC |
| 2023-08-17 | 08-17 | 667, L.P. | Director,TenPercentOwner | P 公開市場買進 | 7.7K | 0.69 | 5K | 489K | SEC |
| 2023-08-17 | 08-17 | BAKER JULIAN | Director,TenPercentOwner | P 公開市場買進 | 93.1K | 0.69 | 64K | 5.6M | SEC |
| 2023-08-17 | 08-17 | BAKER JULIAN | Director,TenPercentOwner | P 公開市場買進 | 7.7K | 0.69 | 5K | 489K | SEC |
| 2023-08-17 | 08-17 | BAKER JULIAN | Director,TenPercentOwner | P 公開市場買進 | 5.0K | 0.69 | 3K | 494K | SEC |
| 2023-08-17 | 08-17 | BAKER BROS. ADVISORS LP | Director,TenPercentOwner | P 公開市場買進 | 7.7K | 0.69 | 5K | 489K | SEC |
| 2023-08-17 | 08-17 | Baker Brothers Life Sciences LP | Director,TenPercentOwner | P 公開市場買進 | 93.1K | 0.69 | 64K | 5.6M | SEC |
| 2023-08-17 | 08-17 | BAKER JULIAN | Director,TenPercentOwner | P 公開市場買進 | 61.1K | 0.69 | 42K | 5.6M | SEC |
| 2023-08-17 | 08-17 | Baker Brothers Life Sciences LP | Director,TenPercentOwner | P 公開市場買進 | 7.7K | 0.69 | 5K | 489K | SEC |
| 2023-08-17 | 08-17 | 667, L.P. | Director,TenPercentOwner | P 公開市場買進 | 93.1K | 0.69 | 64K | 5.6M | SEC |
| 2023-08-17 | 08-17 | BAKER FELIX | Director,TenPercentOwner | P 公開市場買進 | 61.1K | 0.69 | 42K | 5.6M | SEC |
| 2023-08-17 | 08-17 | 667, L.P. | Director,TenPercentOwner | P 公開市場買進 | 61.1K | 0.69 | 42K | 5.6M | SEC |
| 2023-08-16 | 08-17 | BAKER JULIAN | Director,TenPercentOwner | P 公開市場買進 | 4.4K | 0.68 | 3K | 5.5M | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| SAMSARA BIOCAPITAL, LLC | 1.7M | 54.0M | 新進 | 新進 |
| Casdin Capital, LLC | 1.5M | 48.6M | 新進 | 新進 |
| Redmile Group, LLC | 1.4M | 44.4M | 新進 | 新進 |
| RTW INVESTMENTS, LP | 1.4M | 42.8M | 新進 | 新進 |
| EcoR1 Capital, LLC | 1.3M | 40.0M | 新進 | 新進 |
| BlackRock, Inc. | 1.1M | 33.3M | 新進 | 新進 |
| BAKER BROS. ADVISORS LP | 992K | 31.2M | 新進 | 新進 |
| Balyasny Asset Management L.P. | 819K | 25.7M | 新進 | 新進 |
| Trails Edge Capital Partners, LP | 715K | 22.5M | 新進 | 新進 |
| TORONTO DOMINION BANK | 681K | 21.4M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 537K | 16.9M | 新進 | 新進 |
| JENNISON ASSOCIATES LLC | 519K | 16.3M | 新進 | 新進 |
| 城堡 CITADEL ADVISORS LLC | 409K | 12.9M | 新進 | 新進 |
| GREAT POINT PARTNERS LLC | 352K | 11.1M | 新進 | 新進 |
| ArrowMark Colorado Holdings LLC | 342K | 10.8M | 新進 | 新進 |
| FMR LLC | 296K | 9.3M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 293K | 9.2M | 新進 | 新進 |
| STATE STREET CORP | 224K | 7.1M | 新進 | 新進 |
| FRANKLIN RESOURCES INC | 204K | 6.4M | 新進 | 新進 |
| MORGAN STANLEY | 192K | 6.0M | 新進 | 新進 |
| UBS Group AG | 171K | 5.4M | 新進 | 新進 |
| BLAIR WILLIAM & CO/IL | 147K | 4.6M | 新進 | 新進 |
| Driehaus Capital Management LLC | 144K | 4.5M | 新進 | 新進 |
| Point72(柯恩) Point72 Asset Management, L.P. | 142K | 4.5M | 新進 | 新進 |
| MOORE CAPITAL MANAGEMENT, LP | 142K | 4.5M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 112 +16 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 112 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 17.3M · 86.5% |
| 合計季末市值 | 544M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 3.1M |
|---|---|
| 與上期比 | +3.2% |
| 佔流通股數 | 15.67% |
| 日均成交量 | 231K |
| 回補天數 | 13.6 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 3.1M | +3.2% | 15.67% | 231K | 13.6 |
| 2026-08-14 | 3.0M | +1.1% | 15.18% | 181K | 16.8 |
| 2026-07-31 | 3.0M | +2.6% | 15.02% | 186K | 16.2 |
| 2026-07-15 | 2.9M | -12.7% | 14.63% | 387K | 7.6 |
| 2026-06-30 | 3.4M | -5.5% | 16.75% | 249K | 13.5 |
| 2026-06-15 | 3.5M | +0.1% | 17.73% | 155K | 22.9 |
| 2026-05-29 | 3.5M | -1.6% | 17.72% | 129K | 27.5 |
| 2026-05-15 | 3.6M | -3.1% | 18.01% | 146K | 24.7 |
| 2026-04-30 | 3.7M | -7.3% | 18.59% | 187K | 19.9 |
| 2026-04-15 | 4.0M | -0.4% | 20.05% | 140K | 28.6 |
| 2026-03-31 | 4.0M | +3.7% | 20.13% | 160K | 25.2 |
| 2026-03-13 | 3.9M | +5.8% | 19.42% | 195K | 19.9 |
| 2026-02-27 | 3.7M | +1.9% | 18.36% | 235K | 15.6 |
| 2026-02-13 | 3.6M | +0.4% | 18.02% | 110K | 32.7 |
| 2026-01-30 | 3.6M | +1.6% | 17.95% | 113K | 31.9 |
| 2026-01-15 | 3.5M | +1.0% | 17.67% | 175K | 20.2 |
| 2025-12-31 | 3.5M | -1.0% | 17.50% | 193K | 18.1 |
| 2025-12-15 | 3.5M | +7.7% | 17.68% | 193K | 18.3 |
| 2025-11-28 | 3.3M | -0.9% | 16.42% | 209K | 15.8 |
| 2025-11-14 | 3.3M | +16.6% | 16.57% | 302K | 11.0 |
| 2025-10-31 | 2.8M | -0.5% | 14.21% | 218K | 13.1 |
| 2025-10-15 | 2.9M | +0.8% | 14.29% | 296K | 9.7 |
| 2025-09-30 | 2.8M | +0.4% | 14.17% | 149K | 19.0 |
| 2025-09-15 | 2.8M | +3.1% | 14.11% | 170K | 16.6 |
| 2025-08-29 | 2.7M | +3.0% | 13.68% | 94.7K | 28.9 |
| 2025-08-15 | 2.7M | +2.5% | 13.29% | 123K | 21.6 |